Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-21

I disagree and perhaps there are Drs. out there who can confirm my view?

Women with IIH tend to be obese with a co-morbidity that justifies prescription of 'other' GLP1 drugs.

There appears to be no other drug approved for IIH so if they run a trial (simplified, as they propose) surely Drs. are obliged to prescribe a solution to IIH that has been proven in a P3 trial to relieve pressure. This means all the other GLP1's are dealt out of the equation.

Then there's TBI.

In the words of Lenny, it ain't over till...